Arrowhead Pharmaceuticals, Inc. (ARWR)
64.52
-0.12
(-0.19%)
USD |
NASDAQ |
Feb 06, 16:00
64.57
+0.05
(+0.08%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Shareholders Equity (Quarterly) : 568.42M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.320B |
| Eli Lilly & Co. | -- |
| Ionis Pharmaceuticals, Inc. | 617.97M |
| Sanofi | -- |
| Cidara Therapeutics, Inc. | 422.39M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.604B |
| Total Liabilities (Quarterly) | 1.041B |
| Debt to Equity Ratio | 1.21 |
| Current Ratio | 3.380 |
| Net Debt Paydown Yield | 0.36% |